Nat Genet:顾东风等发现4个冠心病心梗易感基因

2012-07-10 王丹 健康报

日前,由中国医学科学院阜外心血管病医院副院长顾东风教授领衔的研究团队,通过对3.3万余名中国冠心病患者以及正常对照人群进行的全基因组关联分析,成功鉴定出8个冠心病相关的遗传易感区域,其中4个区域为国际上首次报道。该研究成果于7月1日在线发表于国际著名学术期刊《自然—遗传学》(Nature Genetics)上。 研究人员依托阜外心血管病医院和协作单位的临床和人群研究资源,首先用1515名冠心病患

日前,由中国医学科学院阜外心血管病医院副院长顾东风教授领衔的研究团队,通过对3.3万余名中国冠心病患者以及正常对照人群进行的全基因组关联分析,成功鉴定出8个冠心病相关的遗传易感区域,其中4个区域为国际上首次报道。该研究成果于7月1日在线发表于国际著名学术期刊《自然—遗传学》(Nature Genetics)上。

研究人员依托阜外心血管病医院和协作单位的临床和人群研究资源,首先用1515名冠心病患者和5019名对照人群的基因组DNA进行全基因组遗传变异的关联分析,随后在15460名冠心病患者和11472名对照人群中进行多阶段重复验证,并在8.7万欧洲人群全基因组样本中交叉验证,首次鉴定出2p24.1、4q32.1、6p21.32和12q21.33共4个染色体区域,其遗传变异可显著影响冠心病、心肌梗死的发病风险。同时,还证实了国外报道的6p24.1、6q23.2、9p21.3和12q24.13共4个区域与我国人群冠心病、心肌梗死发病风险相关。

顾东风介绍,冠心病是人类第一位死因,占总死亡的13%。该项研究成果对解析冠心病和心肌梗死的遗传分子机制,以及冠心病预警、高危人群的筛查和预测、临床早期诊断、新药研发具有重要的科学价值。

据介绍,该研究是迄今亚洲最大的冠心病全基因组关联研究,是在国家“973”计划、“863”计划、北京市科委项目以及国家自然科学基金的支持下,由中国医学科学院阜外心血管病医院、中国医科院基础医学研究所、国家人类基因组北方中心、上海交通大学、生物芯片北京国家工程研究中心、中国科学院生物物理研究所等30余家单位合作完成的。

doi:10.1038/ng.2337
PMC:

PMID:

Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease

Xiangfeng Lu,1, 45 Laiyuan Wang,1, 2, 45 Shufeng Chen,1 Lin He,3 Xueli Yang,1 Yongyong Shi,3 Jing Cheng,4, 5 Liang Zhang,4 C Charles Gu,6 Jianfeng Huang,1 Tangchun Wu,7 Yitong Ma,8 Jianxin Li,1 Jie Cao,1 Jichun Chen,1 Dongliang Ge,1 Zhongjie Fan,9 Ying Li,1 Liancheng Zhao,1 Hongfan Li,2 Xiaoyang Zhou,10 Lanying Chen,1 Donghua Liu,1 Jingping Chen,1 Xiufang Duan,1

We performed a meta-analysis of 2 genome-wide association studies of coronary artery disease comprising 1,515 cases and 5,019 controls followed by replication studies in 15,460 cases and 11,472 controls, all of Chinese Han ancestry. We identify four new loci for coronary artery disease that reached the threshold of genome-wide significance (P < 5 × 10?8). These loci mapped in or near TTC32-WDR35, GUCY1A3, C6orf10-BTNL2 and ATP2B1. We also replicated four loci previously identified in European populations (in or near PHACTR1, TCF21, CDKN2A-CDKN2B and C12orf51). These findings provide new insights into pathways contributing to the susceptibility for coronary artery disease in the Chinese Han population.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1879308, encodeId=f90f18e930892, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Dec 31 07:07:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733604, encodeId=f19b1e33604b0, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue May 21 01:07:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819931, encodeId=117e1819931bc, content=<a href='/topic/show?id=644a100144e7' target=_blank style='color:#2F92EE;'>#顾东风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100144, encryptionId=644a100144e7, topicName=顾东风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu Dec 06 07:07:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048460, encodeId=3329204846039, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Oct 14 16:07:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685865, encodeId=fed8168586524, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Fri Oct 26 23:07:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394410, encodeId=62581394410d0, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Thu Jul 12 06:07:00 CST 2012, time=2012-07-12, status=1, ipAttribution=)]
    2012-12-31 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1879308, encodeId=f90f18e930892, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Dec 31 07:07:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733604, encodeId=f19b1e33604b0, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue May 21 01:07:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819931, encodeId=117e1819931bc, content=<a href='/topic/show?id=644a100144e7' target=_blank style='color:#2F92EE;'>#顾东风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100144, encryptionId=644a100144e7, topicName=顾东风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu Dec 06 07:07:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048460, encodeId=3329204846039, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Oct 14 16:07:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685865, encodeId=fed8168586524, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Fri Oct 26 23:07:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394410, encodeId=62581394410d0, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Thu Jul 12 06:07:00 CST 2012, time=2012-07-12, status=1, ipAttribution=)]
    2013-05-21 canlab
  3. [GetPortalCommentsPageByObjectIdResponse(id=1879308, encodeId=f90f18e930892, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Dec 31 07:07:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733604, encodeId=f19b1e33604b0, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue May 21 01:07:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819931, encodeId=117e1819931bc, content=<a href='/topic/show?id=644a100144e7' target=_blank style='color:#2F92EE;'>#顾东风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100144, encryptionId=644a100144e7, topicName=顾东风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu Dec 06 07:07:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048460, encodeId=3329204846039, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Oct 14 16:07:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685865, encodeId=fed8168586524, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Fri Oct 26 23:07:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394410, encodeId=62581394410d0, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Thu Jul 12 06:07:00 CST 2012, time=2012-07-12, status=1, ipAttribution=)]
    2012-12-06 wwzzly
  4. [GetPortalCommentsPageByObjectIdResponse(id=1879308, encodeId=f90f18e930892, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Dec 31 07:07:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733604, encodeId=f19b1e33604b0, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue May 21 01:07:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819931, encodeId=117e1819931bc, content=<a href='/topic/show?id=644a100144e7' target=_blank style='color:#2F92EE;'>#顾东风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100144, encryptionId=644a100144e7, topicName=顾东风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu Dec 06 07:07:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048460, encodeId=3329204846039, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Oct 14 16:07:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685865, encodeId=fed8168586524, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Fri Oct 26 23:07:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394410, encodeId=62581394410d0, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Thu Jul 12 06:07:00 CST 2012, time=2012-07-12, status=1, ipAttribution=)]
    2012-10-14 cy0324
  5. [GetPortalCommentsPageByObjectIdResponse(id=1879308, encodeId=f90f18e930892, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Dec 31 07:07:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733604, encodeId=f19b1e33604b0, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue May 21 01:07:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819931, encodeId=117e1819931bc, content=<a href='/topic/show?id=644a100144e7' target=_blank style='color:#2F92EE;'>#顾东风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100144, encryptionId=644a100144e7, topicName=顾东风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu Dec 06 07:07:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048460, encodeId=3329204846039, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Oct 14 16:07:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685865, encodeId=fed8168586524, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Fri Oct 26 23:07:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394410, encodeId=62581394410d0, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Thu Jul 12 06:07:00 CST 2012, time=2012-07-12, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1879308, encodeId=f90f18e930892, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Dec 31 07:07:00 CST 2012, time=2012-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733604, encodeId=f19b1e33604b0, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue May 21 01:07:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819931, encodeId=117e1819931bc, content=<a href='/topic/show?id=644a100144e7' target=_blank style='color:#2F92EE;'>#顾东风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100144, encryptionId=644a100144e7, topicName=顾东风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu Dec 06 07:07:00 CST 2012, time=2012-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048460, encodeId=3329204846039, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Oct 14 16:07:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685865, encodeId=fed8168586524, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Fri Oct 26 23:07:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394410, encodeId=62581394410d0, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Thu Jul 12 06:07:00 CST 2012, time=2012-07-12, status=1, ipAttribution=)]

相关资讯

Nat Immun:科学家发现免疫系统对膜融合的识别机制

科学家在《自然—免疫学》Nature Immunology上刊文称,他们发现了一些有关免疫系统是如何识别膜融合—一种发生在病毒感染细胞初期的生理过程——的线索。 研究者发现,当小鼠细胞暴露在病毒样颗粒或者缺少遗传物质和已知刺激分子的人工脂质体这两类物质中,不管是活体实验还是试管实验,其仍然可以产生强烈的免疫应答。虽然不能激活任何传统意义上的病原体识别通路,但上述两种物质仍可以与细胞膜融合。 膜

Nat Medicine:钱友存等自身免疫性疾病研究取得新突破

中科院上海生命科学研究院/上海交通大学医学院健康科学研究所多年来致力于生物医学转化研究,组织生物学专家与临床医生联合攻关、协同创新,对影响人口健康的重大疾病进行深入研究。钱友存研究员领导的研究组和上海交通大学医学院附属仁济医院风湿病学硏究所所长沈南教授(兼健康所分子风湿病学研究组组长)领导的研究组利用仁济医院丰富的临床资源,以临床发现的核心问题为出发点,发挥各自在自身免疫性疾病研究方面已有的优势,

Nat Neurosci:睡眠有助增强运动记忆

据近期发表在《自然—神经科学》Nature Neuroscience上的一项研究显示,睡眠能帮助改善一系列手指运动的锻炼。这使得睡眠对于记忆的重要性再次得到强调,在睡眠期间对记忆力进行选择性引导改进也变成一种可能。 Ken Paller等人先让受试者学习用键盘演奏两种不同乐曲。然后让受试者伴随着他们所演奏的其中一首曲子小睡90分钟。通过用脑电图记录大脑电流活动,研究小组发现在慢波睡眠中,受试者大

Nat Struc & Mol Biol:苏晓东等解析先天免疫信号转导通路中的重要接头及感应蛋白

2012年6月25日,《自然·结构与分子生物学》(Nature structural and molecular biology, NSMB) 在线发表了我校生命科学学院蛋白质与植物基因研究国家重点实验室及生物动态成像中心(BIOPIC)苏晓东教授研究组的论文“The structural basis for the sensing and binding of cyclic di-GMP by

Nat Immun:Notch信号通路调控巨噬细胞极化机制获进展

近年来,胰岛素抵抗靶细胞如肝脏、脂肪、骨骼肌细胞及单核巨噬细胞在促炎/抗炎平衡中的调控作用越来越受到人们的关注。中山大学附属第三医院内分泌代谢病学科许海霞医生做为第一作者之一完成的“Notch信号通路调控巨噬细胞极化机制”相关研究取得突破性进展,论著已被Nature Immunology (影响因子25.668)接受,并于5月20日网络在线发表(Nat. Immunol.2012 May 20 A

Nat Immun:干扰素的产生会抑制抗菌应答

在病毒感染过程中,产生干扰素(抗病毒应答的一种主要介体)所需要的相关免疫通路的激活会抑制一种对抵抗细菌感染有重要作用的细胞因子IL-12的产生,这是日前出版的《自然—免疫学》Nature Immunology上一项研究得出的结论。 一些受体可针对入侵的病原体激活相应的免疫介体。由这些受体激活的信号通路可通过数种方式相互作用,包括协作、互补、代偿等。Tadatsugu Taniguchi等人观察到